Industry Points Out Transparency Issues With FDA Device Plan
Industry representatives and physicians on Monday praised the U.S. Food and Drug Administration's proposal to increase its post-approval monitoring of medical devices, though they expressed concern about the level of transparency...To view the full article, register now.
Already a subscriber? Click here to view full article